Search results
Campaign fuels efforts to find better treatments for blood cancers in children
NBC Dallas Fort Worth· 12 hours agoLeukemia and Lymphoma Society's (LLS) Dare to Dream project hopes to raise money for research of...
EHA 2024: Odronextamab shows promise in ELM-2 study for follicular lymphoma
Clinical Trials Arena via Yahoo Finance· 2 days agoFollicular lymphoma (FL) is a chronic disease that accounts for about 20% of non-Hodgkin's lymphoma...
...Study Demonstrates Columvi Significantly Extends Survival in People With Relapsed or Refractory...
Morningstar· 4 days agoGenentech’s Phase III STARGLO Study Demonstrates Columvi Significantly Extends Survival in People With Relapsed or Refractory Diffuse Large B-cell Lymphoma – The study met ...
Reliable Subaru and The Leukemia & Lymphoma Society donate blankets to cancer patients
Springfield News-Leader via Yahoo News· 4 days agoReliable Subaru partnered with The Leukemia & Lymphoma Society to support patients facing cancer at...
Michael Vaughan: If I went through this ordeal at 80, I would have wanted to be shot
The Telegraph via Yahoo News· 1 hour agoIt was during last autumn’s Dunhill Links at St Andrews, golf’s annual fusion of sport and...
AstraZeneca reports positive data from Phase III mantle cell lymphoma trial
Clinical Trials Arena via Yahoo Finance· 2 days agoAstraZeneca Oncology R&D executive vice-president Susan Galbraith said: “The ECHO trial data...
Rapid test of cerebrospinal fluid found to decrease time to diagnosis for brain tumors
Medical Xpress· 18 hours agoThe team evaluated the technique known as TetRS (Targeted Rapid Sequencing) among 70 patients...
Regeneron (REGN) Outperforms Industry YTD: What Lies Ahead?
Zacks via Yahoo Finance· 14 hours agoThe FDA, however, issued complete response letters (CRLs) for its BLA for odronextamab. The BLA is...
Three-Drug Regimen Shows OS Benefit in Third-Line DLBCL
MedPage Today· 2 days agoLoretta Nastoupil, MD, leads a discussion on the ECHELON-3 trial results
Mustang (MBIO) Soars 477% on Data From Rare Blood Cancer Study
Zacks· 1 day agoFree Report) reported updated results from a cohort of an ongoing phase I/II study evaluating its lead clinical candidate MB-106 in patients with Waldenstrom macroglobulinemia (WM), a rare form ...